Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemia

Haematologica. 2019 May;104(5):868-871. doi: 10.3324/haematol.2018.205955. Epub 2019 Mar 28.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics*
  • High-Throughput Nucleotide Sequencing / methods*
  • Humans
  • Leukemia, Myeloid, Acute / genetics*
  • Leukemia, Myeloid, Acute / pathology
  • Leukemia, Myeloid, Acute / therapy
  • Neoplasm, Residual / diagnosis*
  • Neoplasm, Residual / genetics
  • Neoplasm, Residual / therapy
  • Predictive Value of Tests
  • Risk Assessment / methods*
  • Risk Factors

Substances

  • Biomarkers, Tumor